Nippon Shinyaku Co., Ltd.
Records under this name other than the patents Nippon Shinyaku Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 62 patents it holds.
Back to Nippon Shinyaku Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,835,446 | Quinazoline Derivatives and Pharmaceutical Compositions Thereof Lapsed on the fee record Ended Sep 16, 2026 · High confidence | Lapsed on the fee record | Ended Sep 16, 2026 | High confidence |
| US 11,382,912 | Controlled-Release Preparation Lapsed on the fee record Ended Jul 12, 2026 · High confidence | Lapsed on the fee record | Ended Jul 12, 2026 | High confidence |
| US 8,673,891 | Aminopyrazine derivative and medicine Lapsed on the fee record Ended Mar 18, 2026 · USPTO record | Lapsed on the fee record | Ended Mar 18, 2026 | USPTO record |
| US 7,655,768 | Galactose derivative, drug carrier and medicinal composition Term ended Term ended Mar 6, 2026 · USPTO record | Term ended | Term ended Mar 6, 2026 | USPTO record |
| US 9,890,381 | Antisense nucleic acids Lapsed on the fee record Ended Feb 13, 2026 · USPTO record | Lapsed on the fee record | Ended Feb 13, 2026 | USPTO record |
| US 8,586,591 | Aminopyrazine derivative and medicine Lapsed on the fee record Ended Nov 19, 2025 · USPTO record | Lapsed on the fee record | Ended Nov 19, 2025 | USPTO record |
| US 7,728,131 | Amide derivative and medicine Term ended Term ended Sep 2, 2025 · USPTO record | Term ended | Term ended Sep 2, 2025 | USPTO record |
| US 8,431,586 | Quinazoline Derivatives and Pharmaceutical Compositions Thereof Lapsed on the fee record Ended Apr 30, 2025 · High confidence | Lapsed on the fee record | Ended Apr 30, 2025 | High confidence |
| US 7,612,205 | Crystals of quinolinecarboxylic acid derivative solvate Term ended Term ended Jul 26, 2024 · USPTO record | Term ended | Term ended Jul 26, 2024 | USPTO record |
| US 7,276,525 | Osteogenesis-promotion enhancer and method of screening the same Term ended Term ended Jun 7, 2024 · USPTO record | Term ended | Term ended Jun 7, 2024 | USPTO record |